BUY Kaynes Technology India Ltd. — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))7 Sept 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Dixon Technologies remains IIFL's top EMS pick as mobile manufacturing scheme rolls out
NewsCnbc-Tv18·4 Sept · 2d ago
Explained: Why Jefferies prefers Kaynes Tech shares over Dixon Tech; urges caution on Syrma SGS
NewsEt-Markets·31 Aug · 6d ago
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·24 Aug · 2w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Kaynes Technology India
- BUY — Ansh Jogendra Bhilwar23 Oct 2026 · ~2 weeks · target ₹3,550 · SL hit
- SELL — Kunal Bothra21 Oct 2026 · Same day · target ₹3,080 · Expired
- SELL — Rakesh Bansal9 Oct 2026 · ~2 weeks · target ₹3,110 · SL hit
- SELL — Rakesh Bansal8 Oct 2026 · Same day · target ₹3,220 · Expired
- SELL — Somil Mehta, Sharekhan6 Oct 2026 · ~2 weeks · target ₹3,000 · Expired
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

